PD-L1 (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "PD-L1" in Spanish language version.

refsWebsite

Global rank Spanish rank

18nih.gov

4^th place

17doi.org

2^nd place

1nature.com

234^th place

123^rd place

1cancer.org

3,680^th place

3,012^th place

cancer.org (Global: 3,680^th place; Spanish: 3,012^th place)

«Immune checkpoint inhibitors to treat cancer». American Cancer Society. Consultado el 27 de marzo de 2017.

doi.org (Global: 2^nd place; Spanish: 2^nd place)

dx.doi.org

Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. (julio de 2004). «SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation». Journal of Immunology 173 (2): 945-54. PMID 15240681. doi:10.4049/jimmunol.173.2.945.
Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. (Abril de 2008). «B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells». Blood 111 (7): 3635-43. PMID 18223165. doi:10.1182/blood-2007-11-123141.
Clark CA, Gupta HB, Sareddy G, Pandeswara S, Lao S, Yuan B, Drerup JM, Padron A, Conejo-Garcia J, Murthy K, Liu Y, Turk MJ, Thedieck K, Hurez V, Li R, Vadlamudi R, Curiel TJ. (Diciembre de 2016). «Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.». Cancer Research 76 (23): 6964-74. PMID 27671674. doi:10.1158/0008-5472.CAN-16-0258.
Gato-Cañas M, Zuazo M, Arasanz H, Ibañez-Vea M, Lorenzo L, Fernandez-Hinojal G, Vera R, Smerdou C, Martisova E, Arozarena I, Wellbrock C, Llopiz D, Ruiz M, Sarobe P, Breckpot K, Kochan G, Escors D. (Agosto de 2017). «PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity». Cell Reports 20 (8): 1818-29. PMID 28834746. doi:10.1016/j.celrep.2017.07.075.
Dong H, Zhu G, Tamada K, Chen L. (diciembre de 1999). «B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion». Nature Medicine 5 (12): 1365-9. PMID 10581077. doi:10.1038/70932.
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L. (agosto de 2002). «Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion». Nature Medicine 8 (8): 793-800. PMID 12091876. doi:10.1038/nm730.
Lin DY1, Tanaka Y, Iwasaki M, Gittis AG, Su HP, Mikami B, Okazaki T, Honjo T, Minato N, Garboczi DN. (Diciembre de 2007). «The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors». PNAS 105 (8): 3011-3016. PMID 18287011. doi:10.1073/pnas.0712278105.
Butte MJ, Peña-Cruz V, Kim MJ, Freeman GJ, Sharpe AH. (agosto de 2008). «Interaction of human PD-L1 and B7-1». Molecular Immunology 45 (13): 3567-72. PMC 3764616. PMID 18585785. doi:10.1016/j.molimm.2008.05.014.
Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA, Wooters J, Qiu Y, Jussif JM, Carter LL, Wood CR, Chaudhary D. (septiembre de 2004). «PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta». FEBS Letters 574 (1-3): 37-41. PMID 15358536. doi:10.1016/j.febslet.2004.07.083.
Karwacz K, Bricogne C, MacDonald D, Arce F, Bennett CL, Collins M, Escors D. (octubre de 2011). «PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells». EMBO Molecular Medicine 3 (10): 581-92. PMC 3191120. PMID 21739608. doi:10.1002/emmm.201100165.
Flies DB, Chen L (abril de 2007). «The new B7s: playing a pivotal role in tumor immunity». Journal of Immunotherapy 30 (3): 251-60. PMID 17414316. doi:10.1097/CJI.0b013e31802e085a.
Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H (noviembre de 2002). «Expression of programmed death 1 ligands by murine T cells and APC». Journal of Immunology 169 (10): 5538-45. PMID 12421930. doi:10.4049/jimmunol.169.10.5538.
Lee SJ, Jang BC, Lee SW, Yang YI, Suh SI, Park YM, Oh S, Shin JG, Yao S, Chen L, Choi IH (febrero de 2006). «Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274)». FEBS Letters 580 (3): 755-62. PMID 16413538. doi:10.1016/j.febslet.2005.12.093.
Gong AY, Zhou R, Hu G, Li X, Splinter PL, O'Hara SP, LaRusso NF, Soukup GA, Dong H, Chen XM (febrero de 2009). «MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes». Journal of Immunology 182 (3): 1325-33. PMC 2652126. PMID 19155478. doi:10.4049/jimmunol.182.3.1325.
Gevensleben H, Holmes EE, Goltz D, Dietrich J, Sailer V, Ellinger J, Dietrich D, Kristiansen G (noviembre de 2016). «PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy». Oncotarget 7 (48): 79943-79955. PMC 5346762. PMID 27835597. doi:10.18632/oncotarget.13161.
Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED (diciembre de 2004). «Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target». Proceedings of the National Academy of Sciences of the United States of America 101 (49): 17174-9. PMC 534606. PMID 15569934. doi:10.1073/pnas.0406351101.
Velcheti V, Schalper KA, Carvajal DE, Anagnostou VK, Syrigos KN, Sznol M, Herbst RS, Gettinger SN, Chen L, Rimm DL (enero de 2014). «Programmed death ligand-1 expression in non-small cell lung cancer». Laboratory Investigation; A Journal of Technical Methods and Pathology 94 (1): 107-16. PMID 24217091. doi:10.1038/labinvest.2013.130.

nature.com (Global: 234^th place; Spanish: 123^rd place)

Velcheti V, Schalper KA, Carvajal DE, Anagnostou VK, Syrigos KN, Sznol M, Herbst RS, Gettinger SN, Chen L, Rimm DL (enero de 2014). «Programmed death ligand-1 expression in non-small cell lung cancer». Laboratory Investigation; A Journal of Technical Methods and Pathology 94 (1): 107-16. PMID 24217091. doi:10.1038/labinvest.2013.130.

nih.gov (Global: 4^th place; Spanish: 4^th place)

ncbi.nlm.nih.gov

«Entrez Gene: CD274 CD274 molecule».
Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. (julio de 2004). «SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation». Journal of Immunology 173 (2): 945-54. PMID 15240681. doi:10.4049/jimmunol.173.2.945.
Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. (Abril de 2008). «B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells». Blood 111 (7): 3635-43. PMID 18223165. doi:10.1182/blood-2007-11-123141.
Clark CA, Gupta HB, Sareddy G, Pandeswara S, Lao S, Yuan B, Drerup JM, Padron A, Conejo-Garcia J, Murthy K, Liu Y, Turk MJ, Thedieck K, Hurez V, Li R, Vadlamudi R, Curiel TJ. (Diciembre de 2016). «Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.». Cancer Research 76 (23): 6964-74. PMID 27671674. doi:10.1158/0008-5472.CAN-16-0258.
Gato-Cañas M, Zuazo M, Arasanz H, Ibañez-Vea M, Lorenzo L, Fernandez-Hinojal G, Vera R, Smerdou C, Martisova E, Arozarena I, Wellbrock C, Llopiz D, Ruiz M, Sarobe P, Breckpot K, Kochan G, Escors D. (Agosto de 2017). «PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity». Cell Reports 20 (8): 1818-29. PMID 28834746. doi:10.1016/j.celrep.2017.07.075.
Dong H, Zhu G, Tamada K, Chen L. (diciembre de 1999). «B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion». Nature Medicine 5 (12): 1365-9. PMID 10581077. doi:10.1038/70932.
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L. (agosto de 2002). «Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion». Nature Medicine 8 (8): 793-800. PMID 12091876. doi:10.1038/nm730.
Lin DY1, Tanaka Y, Iwasaki M, Gittis AG, Su HP, Mikami B, Okazaki T, Honjo T, Minato N, Garboczi DN. (Diciembre de 2007). «The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors». PNAS 105 (8): 3011-3016. PMID 18287011. doi:10.1073/pnas.0712278105.
Butte MJ, Peña-Cruz V, Kim MJ, Freeman GJ, Sharpe AH. (agosto de 2008). «Interaction of human PD-L1 and B7-1». Molecular Immunology 45 (13): 3567-72. PMC 3764616. PMID 18585785. doi:10.1016/j.molimm.2008.05.014.
Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA, Wooters J, Qiu Y, Jussif JM, Carter LL, Wood CR, Chaudhary D. (septiembre de 2004). «PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta». FEBS Letters 574 (1-3): 37-41. PMID 15358536. doi:10.1016/j.febslet.2004.07.083.
Karwacz K, Bricogne C, MacDonald D, Arce F, Bennett CL, Collins M, Escors D. (octubre de 2011). «PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells». EMBO Molecular Medicine 3 (10): 581-92. PMC 3191120. PMID 21739608. doi:10.1002/emmm.201100165.
Flies DB, Chen L (abril de 2007). «The new B7s: playing a pivotal role in tumor immunity». Journal of Immunotherapy 30 (3): 251-60. PMID 17414316. doi:10.1097/CJI.0b013e31802e085a.
Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H (noviembre de 2002). «Expression of programmed death 1 ligands by murine T cells and APC». Journal of Immunology 169 (10): 5538-45. PMID 12421930. doi:10.4049/jimmunol.169.10.5538.
Lee SJ, Jang BC, Lee SW, Yang YI, Suh SI, Park YM, Oh S, Shin JG, Yao S, Chen L, Choi IH (febrero de 2006). «Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274)». FEBS Letters 580 (3): 755-62. PMID 16413538. doi:10.1016/j.febslet.2005.12.093.
Gong AY, Zhou R, Hu G, Li X, Splinter PL, O'Hara SP, LaRusso NF, Soukup GA, Dong H, Chen XM (febrero de 2009). «MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes». Journal of Immunology 182 (3): 1325-33. PMC 2652126. PMID 19155478. doi:10.4049/jimmunol.182.3.1325.
Gevensleben H, Holmes EE, Goltz D, Dietrich J, Sailer V, Ellinger J, Dietrich D, Kristiansen G (noviembre de 2016). «PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy». Oncotarget 7 (48): 79943-79955. PMC 5346762. PMID 27835597. doi:10.18632/oncotarget.13161.
Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED (diciembre de 2004). «Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target». Proceedings of the National Academy of Sciences of the United States of America 101 (49): 17174-9. PMC 534606. PMID 15569934. doi:10.1073/pnas.0406351101.
Velcheti V, Schalper KA, Carvajal DE, Anagnostou VK, Syrigos KN, Sznol M, Herbst RS, Gettinger SN, Chen L, Rimm DL (enero de 2014). «Programmed death ligand-1 expression in non-small cell lung cancer». Laboratory Investigation; A Journal of Technical Methods and Pathology 94 (1): 107-16. PMID 24217091. doi:10.1038/labinvest.2013.130.

PD-L1 (Spanish Wikipedia)

cancer.org (Global: 3,680th place; Spanish: 3,012th place)

doi.org (Global: 2nd place; Spanish: 2nd place)